KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other financing activities (2018 - 2023)

Historic Other financing activities for Pacific Biosciences Of California (PACB) over the last 9 years, with Q4 2023 value amounting to $50000.0.

  • Pacific Biosciences Of California's Other financing activities changed N/A to $50000.0 in Q4 2023 from the same period last year, while for Dec 2024 it was $539000.0, marking a year-over-year decrease of 8679.57%. This contributed to the annual value of $7.4 million for FY2023, which is N/A changed from last year.
  • Pacific Biosciences Of California's Other financing activities amounted to $50000.0 in Q4 2023.
  • In the past 5 years, Pacific Biosciences Of California's Other financing activities registered a high of $32.2 million during Q4 2020, and its lowest value of -$30.4 million during Q4 2021.
  • For the 5-year period, Pacific Biosciences Of California's Other financing activities averaged around $3.8 million, with its median value being $1.4 million (2019).
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 2446946.56% in 2020, then plummeted by 19434.85% in 2021.
  • Pacific Biosciences Of California's Other financing activities (Quarter) stood at $131000.0 in 2019, then skyrocketed by 24469.47% to $32.2 million in 2020, then plummeted by 194.35% to -$30.4 million in 2021, then surged by 111.67% to $3.5 million in 2022, then crashed by 98.59% to $50000.0 in 2023.
  • Its last three reported values are $50000.0 in Q4 2023, $489000.0 for Q3 2023, and $3.5 million during Q3 2022.